Details:

Corporate Authors:
Association of Public Health Laboratories (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.) ; Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology and Laboratory Services. ; National Center for HIV, Viral Hepatitis, STDs and TB Prevention (U.S.) ; National Center for Zoonotic, Vector-borne, and Enteric Diseases (U.S.) ; ... More +
Association of Public Health Laboratories (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.) ; Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology and Laboratory Services. ; National Center for HIV, Viral Hepatitis, STDs and TB Prevention (U.S.) ; National Center for Zoonotic, Vector-borne, and Enteric Diseases (U.S.) ; National Center for Environmental Health (U.S.) ; Centers for Disease Control and Prevention (U.S.). Coordinating Office for Terrorism Preparedness and Emergency Response. Less -
Description:
In April 2012, the Centers for Disease Control and Prevention (CDC) published “Good Laboratory Practice Recommendations for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders” as a Morbidity and Mortality Weekly Report (MMWR) Recommendations and Reports publication (1). To assess awareness and use of the recommendations in the MMWR document by the key intended audience — laboratory professionals in biochemical genetic testing (BGT) and public health newborn screening (NBS) laboratories — two facilitated discussion groups were held: one with NBS laboratory professionals and one with BGT laboratory professionals. The groups were held in Atlanta, Georgia, on December 4, 2013, with five and eight participants, respectively. The results presented in this report reflect the feedback from these two discussion groups, summarized into the eight topic areas listed below with clarifying information from the Association of Public Health Laboratories and CDC project team members noted where appropriate.

This project was 100% funded with federal funds from a federal program of $250,000. This report was supported by Cooperative Agreement # U60HM000803 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Services.


Subject:
[+]
Genetic Testing/standards
Infant, Newborn
Laboratories/standards
Metabolism, Inborn Errors/diagnosis
Metabolism, Inborn Errors/genetics
Neonatal Screening/standards
Quality Assurance, Health Care
Quality Control

Document Type:
Report
Funding:
U60HM000803
Name as Subject:
United States. Clinical Laboratory Improvement Amendments of 1988
Place as Subject:
United States
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:a608b73643f877024931efbfe3b7e296bd10d59bdd67a0e481ba966c11614bcd
File Type:

Supporting Files

• No Additional Files

More +